Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.38 USD | -0.02% | +0.06% | +57.32% |
01/05 | North American Morning Briefing : Traders Wait for -2- | DJ |
30/04 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.32% | 2.09B | |
+4.34% | 106B | |
+6.75% | 23.47B | |
-14.38% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-8.90% | 16.78B | |
+7.30% | 14.41B | |
+38.54% | 12.86B | |
+323.75% | 8.78B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- Piper Sandler Adjusts Deciphera Pharmaceuticals' Price Target to $11 From $14, Maintains Neutral Rating